PFE DMA
As of date:8/13/2020
PFE stock price:38.17
PFE 50 DMA:35.38
PFE 200 DMA:35.79
PFE MACD (200-50):0.41

Also see:
PFE Market Cap History
PFE Shares Outstanding History
PFE YTD Return
PFE RSI
PFE MACD
PFE Technical Analysis

CPAA Crosses Below Key Moving Average Level
41 minutes ago


iQIYI (IQ) Shares Cross Below 200 DMA
1 hour, 17 minutes ago


Kulicke & Soffa Industries Breaks Below 200-Day Moving Average - Notable for KLIC
1 hour, 30 minutes ago


Vericel Breaks Below 200-Day Moving Average - Notable for VCEL
1 hour, 30 minutes ago


Notable Two Hundred Day Moving Average Cross - IGHG
1 hour, 48 minutes ago


PURE Storage Breaks Below 200-Day Moving Average - Notable for PSTG
3 hours, 16 minutes ago


BioDelivery Sciences International (BDSI) Shares Cross Above 200 DMA
3 hours, 16 minutes ago


Garrett Motion (GTX) Shares Cross Above 200 DMA
3 hours, 17 minutes ago


GameStop (GME) Shares Cross Above 200 DMA
3 hours, 19 minutes ago


Transcat Breaks Above 200-Day Moving Average - Bullish for TRNS
Thursday, August 13, 5:42 PM


SY Crosses Below Key Moving Average Level
Thursday, August 13, 5:41 PM


HNI Crosses Below Key Moving Average Level
Thursday, August 13, 5:39 PM


Bullish Two Hundred Day Moving Average Cross - PLAN
Thursday, August 13, 5:39 PM


CRH.CA Crosses Above Key Moving Average Level
Thursday, August 13, 3:45 PM


CHSCN Makes Bullish Cross Above Critical Moving Average
Thursday, August 13, 11:32 AM


More Technical Analysis News

PFE DMAPFE MACD
Pfizer is a research-based biopharmaceutical company. Co. is engaged in discovering, developing, manufacturing and distributing of healthcare products, including medicines and vaccines. Co. manages its commercial operations through three businesses: Pfizer Biopharmaceuticals Group, which includes Oncology, Inflammation and Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine business units, as well as a hospital business unit; Upjohn, which includes Co.'s solid oral dose brands such as Lyrica, Lipitor, Norvasc, Celebrex, Viagra, and certain generic medicines; and Consumer Healthcare, which is an over-the-counter medicines business.

When researching a stock like Pfizer, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from PFE Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for PFE stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the PFE 200 day moving average ("PFE 200 DMA"), while one of the most popular "shorter look-backs" is the PFE 50 day moving average ("PFE 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Pfizer.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for PFE:
PFE SEC Filing Email Alerts ServiceExternal link
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pfizer (PFE) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

PKI DMA
PRGO DMA
REGN DMA
RMD DMA
SYK DMA
TFX DMA
TMO DMA
UHS DMA
VAR DMA
VRTX DMA
More Healthcare companies »

 

PFE DMA | www.StockDMA.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.